Viewing Study NCT06206733


Ignite Creation Date: 2025-12-25 @ 2:59 AM
Ignite Modification Date: 2026-03-02 @ 4:55 PM
Study NCT ID: NCT06206733
Status: RECRUITING
Last Update Posted: 2024-03-25
First Post: 2023-12-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ASKB589 in Combination With CAPOX and PD-1 Inhibitor in Patients With Advanced or Metastatic GC/GEJ Adenocarcinoma
Sponsor: AskGene Pharma, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module